Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)
1 clinical trials · Condition
◉ Watch Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)
| Record | Firm | Date |
|---|---|---|
| CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (NCT04653493) | Sabz Biomedicals | 2021-08-01 |
Track Relapsed B Cell Acute Lymphoblastic Leukemia (ALL) automatically
Every clearance here is in the API, with alerts when new ones post.